Lilly crosses one Zyprexa hurdle, faces another-WEB ONLY
On the same day last week, Eli Lilly and Co. cleared a big hurdle regarding its bestselling drug Zyprexa and immediately found itself facing another one. Lilly paid dearly – $1.42 billion – for pleading guilty to improperly marketing the antipsychotic Zyprexa between 1999 and 2001 and to settle lawsuits filed by states. But that […]